Abby Jacobs

596 total citations
7 papers, 401 citations indexed

About

Abby Jacobs is a scholar working on Cancer Research, Small Animals and Molecular Biology. According to data from OpenAlex, Abby Jacobs has authored 7 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cancer Research, 3 papers in Small Animals and 2 papers in Molecular Biology. Recurrent topics in Abby Jacobs's work include Carcinogens and Genotoxicity Assessment (4 papers), Animal testing and alternatives (3 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). Abby Jacobs is often cited by papers focused on Carcinogens and Genotoxicity Assessment (4 papers), Animal testing and alternatives (3 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). Abby Jacobs collaborates with scholars based in United States, United Kingdom and Japan. Abby Jacobs's co-authors include Arthur C. Peters, J. E. Huff, Ronald L. Persing, Clarence E. Chrisp, Robert R. Maronpot, David M. DeMarini, Scot Eustis, Joseph K. Haseman, Toshio Sofuni and Yū F. Sasaki and has published in prestigious journals such as Environmental Health Perspectives, Toxicological Sciences and Mutation Research/Genetic Toxicology and Environmental Mutagenesis.

In The Last Decade

Abby Jacobs

7 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Abby Jacobs United States 7 207 137 110 61 48 7 401
James J. Freeman United States 14 140 0.7× 113 0.8× 152 1.4× 17 0.3× 60 1.3× 27 521
Rodger Curren United States 12 143 0.7× 116 0.8× 142 1.3× 209 3.4× 66 1.4× 21 498
Robert W. Rees United Kingdom 9 192 0.9× 152 1.1× 95 0.9× 77 1.3× 75 1.6× 17 343
Sean C. Gehen United States 14 61 0.3× 163 1.2× 108 1.0× 145 2.4× 95 2.0× 26 537
Rodney A. Miller United States 14 183 0.9× 85 0.6× 174 1.6× 32 0.5× 30 0.6× 31 418
Toshimi Usui Japan 9 137 0.7× 155 1.1× 44 0.4× 37 0.6× 16 0.3× 30 385
Hans‐Jörg Martus Switzerland 9 244 1.2× 288 2.1× 79 0.7× 39 0.6× 90 1.9× 11 446
T B Starr United States 10 243 1.2× 219 1.6× 192 1.7× 20 0.3× 57 1.2× 13 583
Ivan D. Dobrev United States 11 160 0.8× 87 0.6× 178 1.6× 24 0.4× 64 1.3× 15 410
LINVAL R. DEPASS United States 11 107 0.5× 37 0.3× 72 0.7× 38 0.6× 43 0.9× 22 330

Countries citing papers authored by Abby Jacobs

Since Specialization
Citations

This map shows the geographic impact of Abby Jacobs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abby Jacobs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abby Jacobs more than expected).

Fields of papers citing papers by Abby Jacobs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abby Jacobs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abby Jacobs. The network helps show where Abby Jacobs may publish in the future.

Co-authorship network of co-authors of Abby Jacobs

This figure shows the co-authorship network connecting the top 25 collaborators of Abby Jacobs. A scholar is included among the top collaborators of Abby Jacobs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abby Jacobs. Abby Jacobs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Lynch, Anthony M., Daniel Bauer, Elmar Gocke, et al.. (2011). Considerations on photochemical genotoxicity. II: Report of the 2009 International Workshop on Genotoxicity Testing Working Group. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 723(2). 91–100. 8 indexed citations
2.
Chapman, Kathryn, Nick Pullen, Laura Andrews, et al.. (2009). Preclinical development of monoclonal antibodies. mAbs. 1(5). 505–516. 59 indexed citations
3.
Jacobs, Abby, et al.. (2007). Food and Drug Administration, Center for Drug Evaluation and Research. Toxicologic Pathology. 35(2). 323–324. 25 indexed citations
4.
Tweats, David, David H. Blakey, Robert H. Heflich, et al.. (2006). Report of the IWGT working group on strategies and interpretation of regulatory in vivo tests. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 627(1). 78–91. 80 indexed citations
5.
Jacobs, Abby. (2004). Human Carcinogenic Risk Evaluation, Part III: Assessing Cancer Hazard and Risk in Human Drug Development. Toxicological Sciences. 81(2). 260–262. 22 indexed citations
6.
Gocke, Elmar, Susanne Brendler‐Schwaab, Steven J. Bulera, et al.. (2000). Considerations on photochemical genotoxicity: Report of the International Workshop on Genotoxicity Test Procedures Working Group. Environmental and Molecular Mutagenesis. 35(3). 173–184. 46 indexed citations
7.
Huff, J. E., Joseph K. Haseman, David M. DeMarini, et al.. (1989). Multiple-site carcinogenicity of benzene in Fischer 344 rats and B6C3F1 mice.. Environmental Health Perspectives. 82. 125–163. 161 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026